High court to consider patents on genes

WASHINGTON — The building blocks of life are now stacked up before the Supreme Court, as justices consider whether scientists can patent an isolated human gene.

In a case that combines deep thoughts and dollars galore, justices must evaluate a Utah-based company’s patents on two human genes associated with cancer. The court’s eventual answer will clarify a key unanswered question in intellectual property protection. It also could mean gobs of money for researchers, and it could definitely make history.

“This is the first lawsuit brought in the United States challenging the patenting of a human gene,” noted American Civil Liberties Union attorney Sandra Park.

The ACLU is representing an alliance of scientists and others opposed to the human gene patents issued to a company called Myriad Genetics.

Underscoring the high stakes, the case being heard Monday has attracted close attention from many religious, legal and scientific interests. Conservative church leaders with the Southern Baptist Convention oppose the patenting of a human gene; so, for different reasons, does the American Medical Association.

From the other side, Silicon Valley venture capitalists support the human gene patenting; so do giant pharmaceutical companies. They note how costly research has led to the development of DNA-based medical advances such as genetically engineered synthetic insulin and human growth hormone, and cancer screenings.

“It’s extremely expensive to translate a patent into bedside medical tools,” Myriad Genetics president Mark C. Capone said in a telephone interview, adding that “had we not had patent protection,” the company could not have developed its widely used cancer screening tools.

Myriad spent many years and hundreds of millions of dollars on its genetic research, Capone said, with his company’s legal brief elaborating that “countless companies and investors have risked billions of dollars to research and develop advances” because patents protect their work from infringement.

“As a result of our patents, we’ve been able to translate our discoveries into patient care,” Capone said.

The case called Association for Molecular Pathology v. Myriad Genetics starts with the gene, a segment of DNA. Genes define physical traits such as eye color and sex and can influence whether an individual develops conditions such as obesity, diabetes and Alzheimer’s disease.

All told, approximately 22,000 genes make up the human genome, the basis of human inheritance. Genes must be removed from the body and isolated in order to be studied and utilized. Currently, patents have been issued on about 4,000 of the human genes, according to a study by Science magazine.

Park, of the ACLU, said that “certainly, if the court rules in our favor,” some of these other patents might become vulnerable to legal challenge as well. All told, 40,000 patents have been issued for genetic materials from a variety of sources.

“The vast majority of valuable patents in biotechnology are not of this kind, and are not threatened in this case,” said Dr. Robert Cook-Deegan, a research professor at Duke University’s Institute for Genome Sciences and Policy. “However, the intellectual framework that comes out of the decision could have a significant impact on other patents.”

Scientists with Myriad, a firm based in Salt Lake City with revenues of $496 million last year, used mapping tools to identify those genes associated with mutations predisposing a patient to breast and ovarian cancers. Scientists called these the BRCA1 and BRCA2 genes.

The average U.S. woman has a roughly 12 percent risk of developing breast cancer in her lifetime. Women with BRCA mutations, by contrast, face a cumulative risk of up to 85 percent of developing breast cancer.

Myriad obtained a number of patents relating to the isolated BRCA genes.

The patents enable the company to profit and control the shape of future research. Myriad can charge about $3,300 for its genetic-based tests for breast cancer, although the company notes insurance covers most patients. Other scientists, meanwhile, are limited in their own ability to work with the genes, and they say the research shackles extend even to variations on the patent-protected genes.

“Although Myriad has not exercised its authority to stop all research, Myriad’s claims have had a proven chilling effect on research, as laboratories are dissuaded from pursuing scientific work that requires using the patented genes,” the American Civil Liberties Union states in its main legal brief.

Certainly, patents provide powerful protection, which is why researchers want them. Inventors currently can obtain a patent for, as the law puts it, “any new and useful process, machine, manufacture or composition of matter, or any new and useful improvement thereof.”

A gene falls under the category of “composition of matter.” There are limits, though. The Supreme Court has previously ruled that “laws of nature, natural phenomenon and abstract ideas” cannot be patented. Human invention must play a role.

“Myriad’s patented molecules … were never available to the world until Myriad’s scientists applied their inventive faculties to a previously undistinguished mass of genetic matter,” the company’s chief legal brief states.

The company’s opponents counter that Myriad’s isolation of the genes in question did not fundamentally alter their character; meaning the patent improperly extended to what’s naturally occurring. Beyond such legal restrictions, moreover, some critics claim a human gene patent violates ethical precepts.

“Permitting a corporation or person to own this fundamental component of a person corrupts the relationships between human beings and the Creator, and between human beings,” members of the Southern Baptist Convention argued in a legal brief, adding that “patent law emphasizes that the human body is not subject to ownership.”

Following the hourlong oral argument Monday, a court decision is expected by the end of June.

Talk to us

> Give us your news tips.

> Send us a letter to the editor.

> More Herald contact information.

More in Local News

A firefighter stands in silence before a panel bearing the names of L. John Regelbrugge and Kris Regelbrugge during the ten-year remembrance of the Oso landslide on Friday, March 22, 2024, at the Oso Landslide Memorial in Oso, Washington. (Ryan Berry / The Herald)
‘Flood of emotions’ as Oso Landslide Memorial opens on 10th anniversary

Friends, family and first responders held a moment of silence at 10:37 a.m. at the new 2-acre memorial off Highway 530.

Julie Petersen poses for a photo with images of her sister Christina Jefferds and Jefferds’ grand daughter Sanoah Violet Huestis next to a memorial for Sanoah at her home on March 20, 2024 in Arlington, Washington. Peterson wears her sister’s favorite color and one of her bangles. (Annie Barker / The Herald)
‘It just all came down’: An oral history of the Oso mudslide

Ten years later, The Daily Herald spoke with dozens of people — first responders, family, survivors — touched by the deadliest slide in U.S. history.

Victims of the Oso mudslide on March 22, 2014. (Courtesy photos)
Remembering the 43 lives lost in the Oso mudslide

The slide wiped out a neighborhood along Highway 530 in 2014. “Even though you feel like you’re alone in your grief, you’re really not.”

Director Lucia Schmit, right, and Deputy Director Dara Salmon inside the Snohomish County Department of Emergency Management on Friday, March 8, 2024, in Everett, Washington. (Ryan Berry / The Herald)
How Oso slide changed local emergency response ‘on virtually every level’

“In a decade, we have just really, really advanced,” through hard-earned lessons applied to the pandemic, floods and opioids.

Ron and Gail Thompson at their home on Monday, March 4, 2024 in Oso, Washington. (Olivia Vanni / The Herald)
In shadow of scarred Oso hillside, mudslide’s wounds still feel fresh

Locals reflected on living with grief and finding meaning in the wake of a catastrophe “nothing like you can ever imagine” in 2014.

Kelli Littlejohn, who was 11 when her older sister Melissa Lee was murdered, speaks to a group of investigators and deputies to thank them for bringing closure to her family after over 30 years on Thursday, March 28, 2024, at Snohomish County Superior Court in Everett, Washington. (Ryan Berry / The Herald)
‘She can rest in peace’: Jury convicts Bothell man in 1993 killing

Even after police arrested Alan Dean in 2020, it was unclear if he would stand trial. He was convicted Thursday in the murder of Melissa Lee, 15.

Ariel Garcia, 4, was last seen Wednesday morning in an apartment in the 4800 block of Vesper Dr. (Photo provided by Everett Police)
Everett police searching for missing child, 4

Ariel Garcia was last seen Wednesday at an apartment in the 4800 block of Vesper Drive. The child was missing under “suspicious circumstances.”

The rezoned property, seen here from the Hillside Vista luxury development, is surrounded on two sides by modern neighborhoods Monday, March 25, 2024, in Lake Stevens, Washington. (Ryan Berry / The Herald)
Despite petition, Lake Stevens OKs rezone for new 96-home development

The change faced resistance from some residents, who worried about the effects of more density in the neighborhood.

Rep. Suzan DelBene, left, introduces Xichitl Torres Small, center, Undersecretary for Rural Development with the U.S. Department of Agriculture during a talk at Thomas Family Farms on Monday, April 3, 2023, in Snohomish, Washington. (Olivia Vanni / The Herald)
Under new federal program, Washingtonians can file taxes for free

At a press conference Wednesday, U.S. Rep. Suzan DelBene called the Direct File program safe, easy and secure.

Former Snohomish County sheriff’s deputy Jeremie Zeller appears in court for sentencing on multiple counts of misdemeanor theft Wednesday, March 27, 2024, at Snohomish County Superior Court in Everett, Washington. (Ryan Berry / The Herald)
Ex-sheriff’s deputy sentenced to 1 week of jail time for hardware theft

Jeremie Zeller, 47, stole merchandise from Home Depot in south Everett, where he worked overtime as a security guard.

Everett
11 months later, Lake Stevens man charged in fatal Casino Road shooting

Malik Fulson is accused of shooting Joseph Haderlie to death in the parking lot at the Crystal Springs Apartments last April.

T.J. Peters testifies during the murder trial of Alan Dean at the Snohomish County Courthouse on Tuesday, March 26, 2024 in Everett, Washington. (Olivia Vanni / The Herald)
Bothell cold case trial now in jury’s hands

In court this week, the ex-boyfriend of Melissa Lee denied any role in her death. The defendant, Alan Dean, didn’t testify.

Support local journalism

If you value local news, make a gift now to support the trusted journalism you get in The Daily Herald. Donations processed in this system are not tax deductible.